Compare Becton Dickinson and Co (BDX) vs BioNTech SE - ADR (BNTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Becton Dickinson and Co vs BioNTech SE - ADR — how do they compare? Becton Dickinson and Co trades at $180.75 (market cap $49.41B), while BioNTech SE - ADR trades at $92.8 (market cap $23.31B). The key difference: Becton Dickinson and Co is far larger — about 2.1× BioNTech SE - ADR's market cap, and Becton Dickinson and Co pays a 2.32% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BDX | BNTX | |
|---|---|---|
Market Cap | $49.41B | $23.31B |
Sector | Health | Health |
52-Week High | $185.39 | $119.34 |
52-Week Low | $138.62 | $83.89 |
Enterprise Value | $65.51B | $6.60B |
Dividend Yield | 2.32% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →
